AAAAAA

   
Results: 1-8 |
Results: 8
WT1-specific serum antibodies in patients with leukemia
Authors: Gaiger, A Carter, L Greinix, H Carter, D McNeill, PD Houghton, RL Cornellison, CD Vedvick, TS Skeiky, YAW Cheever, MA
Citation: A. Gaiger et al., WT1-specific serum antibodies in patients with leukemia, CLIN CANC R, 7(3), 2001, pp. 761S-765S
Vaccination with Her-2/neu DNA or protein subunits protects against growthof a Her-2/neu-expressing murine tumor
Authors: Foy, TM Bannink, J Sutherland, RA McNeill, PD Moulton, GG Smith, J Cheever, MA Grabstein, K
Citation: Tm. Foy et al., Vaccination with Her-2/neu DNA or protein subunits protects against growthof a Her-2/neu-expressing murine tumor, VACCINE, 19(17-19), 2001, pp. 2598-2606
Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression
Authors: Bernhard, H Huseby, ES Hand, SL Lohmann, M Batten, WY Disis, ML Gralow, JR zum Buschenfelde, KHM Ohlen, C Cheever, MA
Citation: H. Bernhard et al., Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression, IMMUNOBIOL, 201(5), 2000, pp. 568-582
Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis
Authors: Villaret, DB Wang, TT Dillon, D Xu, JC Sivam, D Cheever, MA Reed, SG
Citation: Db. Villaret et al., Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis, LARYNGOSCOP, 110(3), 2000, pp. 374-381
Immunity to WT1 in the animal model and in patients with acute myeloid leukemia
Authors: Gaiger, A Reese, V Disis, ML Cheever, MA
Citation: A. Gaiger et al., Immunity to WT1 in the animal model and in patients with acute myeloid leukemia, BLOOD, 96(4), 2000, pp. 1480-1489
Clinical trials of HER-2/neu peptide-based vaccines
Authors: Disis, ML Cheever, MA
Citation: Ml. Disis et Ma. Cheever, Clinical trials of HER-2/neu peptide-based vaccines, MED INTEL U, 24, 2000, pp. 143-154
Generation of immunity to the HER-2/neu oncogenic protein in patients withbreast and ovarian cancer using a peptide-based vaccine
Authors: Disis, ML Grabstein, KH Sleath, PR Cheever, MA
Citation: Ml. Disis et al., Generation of immunity to the HER-2/neu oncogenic protein in patients withbreast and ovarian cancer using a peptide-based vaccine, CLIN CANC R, 5(6), 1999, pp. 1289-1297
CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells
Authors: Cignetti, A Bryant, E Allione, B Vitale, A Foa, R Cheever, MA
Citation: A. Cignetti et al., CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells, BLOOD, 94(6), 1999, pp. 2048-2055
Risultati: 1-8 |